Search

Displaying results 8491 - 8500 of 10000 in total
  1. Drug

    Camellia japonica seed oil

    go.drugbank.com/drugs/DB14308
    Investigational

    It is not an approved drug.

  2. Drug

    Chamaecyparis obtusa wood oil

    go.drugbank.com/drugs/DB14341
    Investigational

    It is not an approved drug.

    Products: Mosquitoes Go Away
  3. Drug

    Rosa centifolia flower oil

    go.drugbank.com/drugs/DB14363
    Investigational

    It is not an approved drug.

  4. Drug

    Perfosfamide

    go.drugbank.com/drugs/DB12727
    Investigational

    Perfosfamide has been used in trials studying the treatment of Lymphoma, Neuroblastoma, and Multiple Myeloma and Plasma Cell Neoplasm.

  5. Drug

    Basimglurant

    go.drugbank.com/drugs/DB11833
    Investigational

    Basimglurant has been used in trials studying the diagnostic and treatment of Depression, Fragile X Syndrome, and Major Depressive Disorder.

  6. Drug

    WNT-974

    go.drugbank.com/drugs/DB12561
    Investigational

    WNT974 has been used in trials studying the treatment of Metastatic Colorectal Cancer and Squamous Cell Carcinoma, Head And Neck.

    Synonyms: (2,4'-bipyridine)-5-acetamide, 2',3-dimethyl-N-(5-(2-pyrazinyl)-2-pyridinyl)-
  7. Drug

    Emapunil

    go.drugbank.com/drugs/DB12666
    Investigational

    Emapunil has been used in trials studying the basic science and diagnostic of Baseline, Blocking Receptor Binding, and Neurodegenerative Disorders.

  8. Drug

    5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole

    go.drugbank.com/drugs/DB08724
    Experimental

    This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. This medication is known to target genome polyprotein.

  9. Drug

    Linopristin

    go.drugbank.com/drugs/DB19296
    Experimental

    The combination product was under investigation in clinical trials NCT00653172 and NCT00949130 for treatment of various bacterial infections. … Linopristin is an antibiotic of the streptogramin B class. It is one part of the combination product NXL 103, along with [Virginiamycin M1].

  10. Drug

    Rintodestrant

    go.drugbank.com/drugs/DB21472
    Investigational

    Rintodestrant is under investigation in clinical trial NCT03455270 (G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer).